Global Insulin API Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Insulin API Market
The global Insulin API market size is projected to reach US$ 2072.2 million by 2027, from US$ 1692.5 million in 2020, at a CAGR of 2.9% during 2021-2027.
Global Insulin API Scope and Segment
The global Insulin API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Insulin API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Regular Human Insulin
Insulin Analogue
By the end users/application, this report covers the following segments
Fast-Acting
Premix
Long-Acting
Competitive Landscape:
The report provides a list of all the key players in the Insulin API market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Insulin API key manufacturers in this market include:
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma

TABLE OF CONTENT

1 Insulin API Market Overview
1.1 Insulin API Product Overview
1.2 Insulin API Market Segment by Type
1.2.1 Regular Human Insulin
1.2.2 Insulin Analogue
1.3 Global Insulin API Market Size by Type
1.3.1 Global Insulin API Market Size Overview by Type (2016-2027)
1.3.2 Global Insulin API Historic Market Size Review by Type (2016-2030)
1.3.2.1 Global Insulin API Sales Breakdown in Volume by Type (2016-2030)
1.3.2.2 Global Insulin API Sales Breakdown in Value by Type (2016-2030)
1.3.2.3 Global Insulin API Average Selling Price (ASP) by Type (2016-2030)
1.3.3 Global Insulin API Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Insulin API Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Insulin API Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Insulin API Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Insulin API Sales Breakdown by Type (2016-2030)
1.4.2 Europe Insulin API Sales Breakdown by Type (2016-2030)
1.4.3 Asia-Pacific Insulin API Sales Breakdown by Type (2016-2030)
1.4.4 Latin America Insulin API Sales Breakdown by Type (2016-2030)
1.4.5 Middle East and Africa Insulin API Sales Breakdown by Type (2016-2030)

2 Global Insulin API Market Competition by Company
2.1 Global Top Players by Insulin API Sales (2016-2030)
2.2 Global Top Players by Insulin API Revenue (2016-2030)
2.3 Global Top Players Insulin API Price (2016-2030)
2.4 Global Top Manufacturers Insulin API Manufacturing Base Distribution, Sales Area, Product Type
2.5 Insulin API Market Competitive Situation and Trends
2.5.1 Insulin API Market Concentration Rate (2016-2030)
2.5.2 Global 5 and 10 Largest Manufacturers by Insulin API Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin API as of 2020)
2.7 Date of Key Manufacturers Enter into Insulin API Market
2.8 Key Manufacturers Insulin API Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Insulin API Status and Outlook by Region
3.1 Global Insulin API Market Size and CAGR by Region: 2016 VS 2030 VS 2026
3.2 Global Insulin API Historic Market Size by Region
3.2.1 Global Insulin API Sales in Volume by Region (2016-2030)
3.2.2 Global Insulin API Sales in Value by Region (2016-2030)
3.2.3 Global Insulin API Sales (Volume & Value) Price and Gross Margin (2016-2030)
3.3 Global Insulin API Forecasted Market Size by Region
3.3.1 Global Insulin API Sales in Volume by Region (2022-2027)
3.3.2 Global Insulin API Sales in Value by Region (2022-2027)
3.3.3 Global Insulin API Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Insulin API by Application
4.1 Insulin API Market Segment by Application
4.1.1 Fast-Acting
4.1.2 Premix
4.1.3 Long-Acting
4.2 Global Insulin API Market Size by Application
4.2.1 Global Insulin API Market Size Overview by Application (2016-2027)
4.2.2 Global Insulin API Historic Market Size Review by Application (2016-2030)
4.2.2.1 Global Insulin API Sales Breakdown in Volume, by Application (2016-2030)
4.2.2.2 Global Insulin API Sales Breakdown in Value, by Application (2016-2030)
4.2.2.3 Global Insulin API Average Selling Price (ASP) by Application (2016-2030)
4.2.3 Global Insulin API Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Insulin API Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Insulin API Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Insulin API Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Insulin API Sales Breakdown by Application (2016-2030)
4.3.2 Europe Insulin API Sales Breakdown by Application (2016-2030)
4.3.3 Asia-Pacific Insulin API Sales Breakdown by Application (2016-2030)
4.3.4 Latin America Insulin API Sales Breakdown by Application (2016-2030)
4.3.5 Middle East and Africa Insulin API Sales Breakdown by Application (2016-2030)

5 North America Insulin API by Country
5.1 North America Insulin API Historic Market Size by Country
5.1.1 North America Insulin API Sales in Volume by Country (2016-2030)
5.1.2 North America Insulin API Sales in Value by Country (2016-2030)
5.2 North America Insulin API Forecasted Market Size by Country
5.2.1 North America Insulin API Sales in Volume by Country (2022-2027)
5.2.2 North America Insulin API Sales in Value by Country (2022-2027)

6 Europe Insulin API by Country
6.1 Europe Insulin API Historic Market Size by Country
6.1.1 Europe Insulin API Sales in Volume by Country (2016-2030)
6.1.2 Europe Insulin API Sales in Value by Country (2016-2030)
6.2 Europe Insulin API Forecasted Market Size by Country
6.2.1 Europe Insulin API Sales in Volume by Country (2022-2027)
6.2.2 Europe Insulin API Sales in Value by Country (2022-2027)

7 Asia-Pacific Insulin API by Region
7.1 Asia-Pacific Insulin API Historic Market Size by Region
7.1.1 Asia-Pacific Insulin API Sales in Volume by Region (2016-2030)
7.1.2 Asia-Pacific Insulin API Sales in Value by Region (2016-2030)
7.2 Asia-Pacific Insulin API Forecasted Market Size by Region
7.2.1 Asia-Pacific Insulin API Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Insulin API Sales in Value by Region (2022-2027)

8 Latin America Insulin API by Country
8.1 Latin America Insulin API Historic Market Size by Country
8.1.1 Latin America Insulin API Sales in Volume by Country (2016-2030)
8.1.2 Latin America Insulin API Sales in Value by Country (2016-2030)
8.2 Latin America Insulin API Forecasted Market Size by Country
8.2.1 Latin America Insulin API Sales in Volume by Country (2022-2027)
8.2.2 Latin America Insulin API Sales in Value by Country (2022-2027)

9 Middle East and Africa Insulin API by Country
9.1 Middle East and Africa Insulin API Historic Market Size by Country
9.1.1 Middle East and Africa Insulin API Sales in Volume by Country (2016-2030)
9.1.2 Middle East and Africa Insulin API Sales in Value by Country (2016-2030)
9.2 Middle East and Africa Insulin API Forecasted Market Size by Country
9.2.1 Middle East and Africa Insulin API Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Insulin API Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Insulin API Business
10.1 Novo Nordisk
10.1.1 Novo Nordisk Corporation Information
10.1.2 Novo Nordisk Introduction and Business Overview
10.1.3 Novo Nordisk Insulin API Sales, Revenue and Gross Margin (2016-2030)
10.1.4 Novo Nordisk Insulin API Products Offered
10.1.5 Novo Nordisk Recent Development
10.2 Sanofi-Aventis
10.2.1 Sanofi-Aventis Corporation Information
10.2.2 Sanofi-Aventis Introduction and Business Overview
10.2.3 Sanofi-Aventis Insulin API Sales, Revenue and Gross Margin (2016-2030)
10.2.4 Sanofi-Aventis Insulin API Products Offered
10.2.5 Sanofi-Aventis Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Corporation Information
10.3.2 Eli Lilly Introduction and Business Overview
10.3.3 Eli Lilly Insulin API Sales, Revenue and Gross Margin (2016-2030)
10.3.4 Eli Lilly Insulin API Products Offered
10.3.5 Eli Lilly Recent Development
10.4 Tonghua Dongbao
10.4.1 Tonghua Dongbao Corporation Information
10.4.2 Tonghua Dongbao Introduction and Business Overview
10.4.3 Tonghua Dongbao Insulin API Sales, Revenue and Gross Margin (2016-2030)
10.4.4 Tonghua Dongbao Insulin API Products Offered
10.4.5 Tonghua Dongbao Recent Development
10.5 Ganlee
10.5.1 Ganlee Corporation Information
10.5.2 Ganlee Introduction and Business Overview
10.5.3 Ganlee Insulin API Sales, Revenue and Gross Margin (2016-2030)
10.5.4 Ganlee Insulin API Products Offered
10.5.5 Ganlee Recent Development
10.6 United Laboratory
10.6.1 United Laboratory Corporation Information
10.6.2 United Laboratory Introduction and Business Overview
10.6.3 United Laboratory Insulin API Sales, Revenue and Gross Margin (2016-2030)
10.6.4 United Laboratory Insulin API Products Offered
10.6.5 United Laboratory Recent Development
10.7 Biocon
10.7.1 Biocon Corporation Information
10.7.2 Biocon Introduction and Business Overview
10.7.3 Biocon Insulin API Sales, Revenue and Gross Margin (2016-2030)
10.7.4 Biocon Insulin API Products Offered
10.7.5 Biocon Recent Development
10.8 Amphastar
10.8.1 Amphastar Corporation Information
10.8.2 Amphastar Introduction and Business Overview
10.8.3 Amphastar Insulin API Sales, Revenue and Gross Margin (2016-2030)
10.8.4 Amphastar Insulin API Products Offered
10.8.5 Amphastar Recent Development
10.9 Wockhardt
10.9.1 Wockhardt Corporation Information
10.9.2 Wockhardt Introduction and Business Overview
10.9.3 Wockhardt Insulin API Sales, Revenue and Gross Margin (2016-2030)
10.9.4 Wockhardt Insulin API Products Offered
10.9.5 Wockhardt Recent Development
10.10 Julphar Diabetes
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Insulin API Product Category, Application and Specification
10.10.3 Julphar Diabetes Insulin API Sales, Revenue, Price and Gross Margin (2016-2030)
10.10.4 Main Business Overview
10.10.5 Julphar Diabetes Recent Development
10.11 Torrent Pharma
10.11.1 Torrent Pharma Corporation Information
10.11.2 Torrent Pharma Introduction and Business Overview
10.11.3 Torrent Pharma Insulin API Sales, Revenue and Gross Margin (2016-2030)
10.11.4 Torrent Pharma Insulin API Products Offered
10.11.5 Torrent Pharma Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Insulin API Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Insulin API Industrial Chain Analysis
11.4 Insulin API Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Insulin API Distributors
12.3 Insulin API Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Choose License Type

Checkout Inquiry Sample